You are currently viewing a new version of our website. To view the old version click .

New Insights into Respiratory Diseases Caused by Substance Abuse

This special issue belongs to the section “Respiratory Medicine“.

Special Issue Information

Dear Colleagues,

Tobacco smoking, cannabis smoking, and drugs abuse are, nowadays, very common among young people. In the last few years, researchers have studied and pointed out the deleterious effects of tobacco and cannabis consumption on the respiratory system. The action of tobacco and/or cannabis on the airways may lead to hyperresponsiveness, inflammation, tissue destruction, and lung emphysema. Consequently, tobacco and/or cannabis abuse can cause upper and lower airways diseases, with acute and chronic manifestations and, among the latter, lung cancer represents a possible evolution. Pathogenesis studies investigating the detrimental effects of marijuana on the cells of the respiratory system are in progress. Campaigns for smoking prevention and for cessation of such voluptuary habits have an important role in limiting the spread of respiratory diseases caused by this abuse and an ethical and sociological relevance for young populations. In this Special Issue, we welcome authors to submit papers on recent and new insights into respiratory diseases caused by drugs or tobacco.

Dr. Angela De Palma
Dr. Silvano Dragonieri
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drugs
  • cannabis
  • smoking
  • respiratory diseases
  • prevention
  • treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383